lazertinib 240 MG Oral Tablet

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

lazertinib 240 MG Oral Tablet

240 MG · Oral Tablet · oral

A form of lazertinib →

lazertinib 240 MG Oral Tablet — Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Strength, form, class, interactions & more.

lazertinib 240 MG Oral Tablet

Active ingredient

lazertinib →

Classification

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsKinase Inhibitor

Drug interactions

Lazertinib has several interactions with CYP3A4 and BCRP substrates and inducers.

  • majorstrong and moderate CYP3A4 inducers — decreased lazertinib concentrations, which may reduce efficacy
  • moderateCYP3A4 substrates — increased concentrations of CYP3A4 substrates, which may increase the risk of adverse reactions
  • moderateBCRP substrates — increased concentrations of BCRP substrates, which may increase the risk of adverse reactions

Real-world adverse events (FAERS)

Rash114Infusion Related Reaction68Neuropathy Peripheral36Fatigue35Off Label Use33Paronychia33Diarrhoea29Dyspnoea24

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →